Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy
NCT02597075 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-11-07
Summary
The purpose of this study is to assess whether a structured physical activity program (PA) during palliative chemotherapy improves progression-free survival (PFS) and/or patient-reported outcomes (ESAS-r) in patients with metastatic colorectal cancer.
Conditions
Interventions
- OTHER
-
standard therapy + physical activity program
- OTHER
-
standard therapy
Sponsors & Collaborators
-
Swiss Cancer Institute
lead OTHER
Principal Investigators
-
Viviane Hess, Prof Dr med · University Hospital, Basel, Switzerland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-17
- Primary Completion
- 2021-09-21
- Completion
- 2021-11-30
Countries
- Austria
- Switzerland
Study Locations
More Related Trials
-
The Exercise And Colorectal Cancer Treatment Trial
NCT03975491 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases
NCT03599752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
NCT07263178 ·Status: RECRUITING
-
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients
NCT01453257 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Metronomic Poly-chemotherapy for Metastatic CRC
NCT02280694 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
NCT00230399 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Efficacy Study of AZD6244 in Colorectal Cancer
NCT00514761 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
NCT00625573 ·Status: COMPLETED ·Phase: PHASE2
-
Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer
NCT02117466 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer
NCT05172635 ·Status: COMPLETED
-
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
NCT01607957 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
NCT01729923 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
NCT04227041 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma
NCT01333475 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
NCT06576986 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma
NCT01208194 ·Status: COMPLETED ·Phase: PHASE2
-
Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency
NCT00952016 ·Status: TERMINATED ·Phase: PHASE2
-
FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis
NCT06801665 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
NCT01097265 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma
NCT03096899 ·Status: WITHDRAWN
-
Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT03613194 ·Status: UNKNOWN ·Phase: NA
-
Synergism of Immunomodulation and Tumor Ablation
NCT03101475 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Aflibercept for Metastatic Colorectal Cancer
NCT01669720 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT00628810 ·Status: COMPLETED ·Phase: PHASE2
-
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
NCT00003220 ·Status: COMPLETED ·Phase: PHASE2